Between 14 June 2021 and 4 September 2021, 33 Chinese adolescents who developed acute myocarditis/pericarditis following Comirnaty vaccination were identified. 29 (87.88%) were males and 4 (12.12%) were females, with a median age of 15.25 years. 27 (81.82%) and 6 (18.18%) cases developed acute myocarditis/pericarditis after receiving the second and first dose, respectively. All cases are mild and required only conservative management.
IBTFR$$ claim....oh, these are only MILD cases.
🙄
RE: IBTFR$$ claim....oh, these are only MILD cases.
So, mild Myocarditis cases are an acceptable risk to take for Comirnaty vaccination ( yep, the one actually APPROVED by the FDA )?
Odd that one part says cases were mild and another says significant risk of acute.